Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122785922 | 12278592 | 2 | F | 20160718 | 20160418 | 20160722 | EXP | PHHY2016BR051651 | NOVARTIS | 0.00 | M | Y | 59.00000 | KG | 20160722 | MD | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122785922 | 12278592 | 1 | PS | EXJADE | DEFERASIROX | 1 | Oral | 25 MG/KG, QD (3 TABLETS OF 500 MG) | U | SA336 | 21882 | 25 | MG/KG | DISPERSIBLE TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122785922 | 12278592 | 1 | Sickle cell anaemia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122785922 | 12278592 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122785922 | 12278592 | Back pain | |
122785922 | 12278592 | Musculoskeletal pain | |
122785922 | 12278592 | Pain | |
122785922 | 12278592 | Pain in extremity | |
122785922 | 12278592 | Serum ferritin increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122785922 | 12278592 | 1 | 2013 | 0 |